Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02320058
Title A Multi-Center Phase 2 Open-Label Study to Evaluate Safety and Efficacy in Subjects With Melanoma Metastatic to the Brain Treated With Nivolumab in Combination With Ipilimumab Followed by Nivolumab Monotherapy (CheckMate 204)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

melanoma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Angeles Clinic and Research Institute Los Angeles California 90025 United States Details
UCLA Medical Hematology and Oncology Los Angeles California 90095 United States Details
Stanford University Palo Alto California 94304 United States Details
The California Pacific Medical Research Institute San Francisco California 94115 United States Details
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94158 United States Details
University of Colorado - Cancer Center - PPDS Aurora Colorado 80045 United States Details
Washington Cancer Inst at MedStar Washington Hospital Ctr Washington District of Columbia 20007 United States Details
Weinberg Cancer Institute At Franklin Square Washington District of Columbia 20007 United States Details
Georgetown University Medical Center Washington District of Columbia 20057 United States Details
Mount Sinai Medical Center Miami Beach Florida 33140 United States Details
H Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
The Cleveland Clinic Foundation Weston Florida 33331 United States Details
Winship Cancer Institute, Emory University Atlanta Georgia 30322-1013 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Loyola University Medical Center Maywood Illinois 60153 United States Details
Dana Farber Cancer Institute. Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Massachusetts General Hospital Boston Massachusetts 02215 United States Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
NYU Langone Medical Center New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Case School of Medicine University Hospitals of Cleveland Cleveland Ohio 44106-5055 United States Details
Lehigh Valley Health Network Allentown Pennsylvania 18105 United States Details
St Luke's Health Network Easton Pennsylvania 18045 United States Details
Abramson Cancer Center of The University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Utah - Huntsman Cancer Institute - PPDS Salt Lake City Utah 84112 United States Details
Inova Melanoma and Skin Cancer Center Fairfax Virginia 55905 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field